Pharmacologic treatments for covid-19 patients
Hydroxychloroquine vs Vitamin C
This comparison will not be updated. Last search date 28 Feb, 2022.
Outpatients
Forest plots
(last update: 2021-05-28)
To access all information :
- click here for Outpatients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=396
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04354428 Johnston C, EClinicalMedicine, 2021 Full text Commentary Commentary Commentary |
Public/non profit |
Hydroxychloroquine sulphate+azithromycin Hydroxychloroquine+Placebo Hydroxychloroquine sulphate+azithromycin |
Vitamin C+Placebo Vitamin C+Placebo Hydroxychloroquine+Placebo |
RCT | Outpatients with confirmed COVID-19 (asymptomatic-mild) treated by 5 centers in the USA | N=231 |
Some concerns Details |
|